Quality, Process and Innovation Direction, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Health Services Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
PLoS One. 2022 Jun 13;17(6):e0266202. doi: 10.1371/journal.pone.0266202. eCollection 2022.
The optimal time for initiation of dialysis and which modality to choose as the starting therapy is currently unclear. This systematic review aimed to assess the recommendations across high-quality clinical practice guidelines (CPGs) related to the start of dialysis.
We systematically searched MEDLINE, EMBASE, Web of Science, LILACS, and databases of organisations that develop CPGs between September 2008 to August 2021 for CPGs that addressed recommendations on the timing of initiation of dialysis, selection of dialysis modality, and interventions to support the decision-making process to select a dialysis modality. We used the Appraisal of Guidelines for Research and Evaluation instrument to assess the methodological quality of the CPGs and included only high-quality CPGs. This study is registered in PROSPERO, number CRD42018110325.
We included 12 high-quality CPGs. Six CPGs addressed recommendations related to the timing of initiating dialysis, and all agreed on starting dialysis in the presence of symptoms or signs. Six CPGs addressed recommendations related to the selection of modality but varied greatly in their content. Nine CPGs addressed recommendations related to interventions to support the decision-making process. Eight CPGs agreed on recommended educational programs that include information about dialysis options. One CPG considered using patient decision aids a strong recommendation.
We could have missed potentially relevant guidelines since we limited our search to CPGs published from 2008, and we set up a cut-off point of 60% in domains of the rigour of development and editorial independence.
High-quality CPGs related to the process of starting dialysis were consistent in initiating dialysis in the presence of symptoms or signs and offering patients education at the point of decision-making. There was variability in how CPGs addressed the issue of dialysis modality selection. CPGs should improve strategies on putting recommendations into practice and the quality of evidence to aid decision-making for patients.
The protocol of this systematic review has been registered in the international prospective register of systematic reviews (PROSPERO) under the registration number: CRD CRD42018110325. https://clinicaltrials.gov/ct2/show/CRD42018110325.
目前,启动透析的最佳时间以及选择哪种治疗方式作为起始治疗方法尚不清楚。本系统评价旨在评估与透析起始相关的高质量临床实践指南(CPG)中的推荐意见。
我们系统地检索了 MEDLINE、EMBASE、Web of Science、LILACS 和制定 CPG 的组织数据库,以获取 2008 年 9 月至 2021 年 8 月期间关于透析起始时机、透析方式选择以及支持选择透析方式决策过程的干预措施的 CPG。我们使用评估研究和评估工具来评估 CPG 的方法学质量,并仅纳入高质量的 CPG。本研究已在 PROSPERO 注册,注册号为 CRD42018110325。
我们纳入了 12 项高质量的 CPG。其中 6 项 CPG 涉及与开始透析相关的建议,并且所有 CPG 都同意在出现症状或体征时开始透析。6 项 CPG 涉及有关选择方式的建议,但内容差异很大。9 项 CPG 涉及支持决策过程的干预措施。其中 8 项 CPG 同意推荐包含有关透析选择信息的教育计划。一项 CPG 认为使用患者决策辅助工具是一个强烈的建议。
由于我们的搜索仅限于 2008 年以后发表的 CPG,并且我们在发展严谨性和编辑独立性的领域设定了 60%的截止点,因此我们可能错过了潜在相关的指南。
与启动透析过程相关的高质量 CPG 在出现症状或体征时开始透析并在决策点为患者提供教育方面保持一致。CPG 如何解决透析方式选择问题存在差异。CPG 应改进将建议付诸实践的策略和证据质量,以帮助患者做出决策。
本系统评价的方案已在国际前瞻性系统评价注册库(PROSPERO)中注册,注册号为 CRD CRD42018110325。https://clinicaltrials.gov/ct2/show/CRD42018110325。